Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Cold therapy is also known as cryotherpahy which majorly works as healing technique which exposes the body temperature to extremely cold temperatures for several minutes. The therapy is widely used for recovering procedure and treatment of musculoskeletal disorders, sports medicine, post-operative therapy, and post-trauma therapy. Furthermore, these therapy allows the lessen inflammation, swelling and nerve activity which in turn relieve the pain around the around the muscles, joint and tendons. In addition, cold pain therapy market has emerging demand in Asia Pacific market attributing to increasing accidents, diseases, rising geriatric population, lifestyle changes, rapid urbanization. Moreover, the market is expected to witness the growth at significant pace during the forecast period (2021-2027).
Asia Pacific cold pain therapy market is driven by demand for cold pain therapy in the sports injury. Besides, growing awareness among consumers about the effectiveness of the cold pain therapy products for different tissue damage, sports injuries has propel the demand for the Asia Pacific cold pain therapy market. Also, rise in geriatric population, increasing prevalence of arthritis, awareness about the availability of cost-effective, supporting initiative of the government are accelerating the demand for the Asia Pacific cold pain therapy market
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the Asia Pacific cold pain therapy market. In addition, complete analysis of changes on the Asia Pacific cold pain therapy market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on global economies, international trade, business investments, GDP and marketing strategies of key players present in the market. Due to COVID-19 the market was affected moderately due to slow production and disruption of the supply chain for months. However, post COVID-19 the market is expected to rise in significant pace.
The cold pain therapy market is segmented based on by product, therapy, application, distribution and country.
The cold pain therapy market is available in different product type like otc products, prescription products. OTC Products is segmented into pharmaceuticals and medical devices whereas prescription products includes motorized devices and non-motorized devices .Besides, pharmaceuticals is bifurcated to gels, ointments and creams, patches, roll-ons, sprays and foams and Medical devices including cooling towels, compresses, cold packs, pads and wraps. OTC products have increasing demand in the Asia Pacific cold pain therapy market due to growing supply chain and distribution has fueled the availability of products in different stores for consumers. Besides, guidance by the pharmacist for OTC products has boosted the market growth to huge extend.
The cold pain therapy market comprises of therapy like icepack therapy, chamber therapy and cryosurgery. Icepack therapy followed by chamber therapy is expected to be used widely in the region. The growth of the segment is attributed to rising requirement due to increasing road accidents. Besides, growing sports injuries is accelerating the demand for the market.
The cold pain therapy market finds application in musculoskeletal disorders, sports medicine, post-operative therapy, and post-trauma therapy. Musculoskeletal disorders is anticipated to dominate attributing to increasing burden of population with lower back pain. Also, geriatric population with musculoskeletal disorders is providing ample of growth opportunity for the Asia Pacific cold pain therapy market. Also, sports medicine, followed by post-operative therapy are likely to contribute healthy growth in the Asia Pacific cold pain therapy market.
The cold pain therapy market has its distribution through hospitals pharmacies, online pharmacies, retail pharmacies. Retail pharmacies are expected to lead in the Asia Pacific cold pain therapy market as the region has growing number of retail pharmacies offering cold pain therapy products, besides these pharmacies provides these products at lower cost units, with better access, is further driving the growth of segment in Asia Pacific market. Also, online pharmacies is expected to witness the growth at the fastest pace during the projection period.
The Asia Pacific cold pain therapy market is studied for the following countries like China, India, Japan and Rest of APAC. Asia Pacific is anticipated to emerging growth opportunities attributing to increasing sports injuries, rising geriatric population, accidents has propel the demand for the cold pain therapy market in Asia Pacific region. Besides, China followed by India dominated the market in Asia Pacific region owing to increasing preference for cold therapy products gels, ointments and creams, patches, cooling towels, compresses, cold packs and others. Also, rising healthcare infrastructure, awareness for cold therapy products has accelerated the demand for the market.
The key players in Asia Pacific cold pain therapy market are Sanofi, 3M, Medtronic, Pfizer, Hisamitsu Pharmaceutical, ROHTO Pharmaceutical, Beiersdorf, Johnson & Johnson, Medline Industries, Ossur, Performance Health, Breg, Romsons Group of Industries, Unexo Life Sciences, Bird & Cronin, DJO Global, DeRoyal Industries, Inc., Performance Health, Bruder Healthcare, Hot and Cold Company and Polar Products Inc among others.
The report analyses the Asia Pacific cold pain therapy market based on by product, therapy, application, distribution and country. The cold pain therapy market is available in different product type like otc products, prescription products. OTC products have increasing demand in the Asia Pacific cold pain therapy market due to growing supply chain and distribution has fueled the availability of products. The cold pain therapy market comprises of therapy like icepack therapy, chamber therapy and cryosurgery. Icepack therapy followed by chamber therapy is expected to be used widely in the region. The cold pain therapy market finds application in musculoskeletal disorders, sports medicine, post-operative therapy, and post-trauma therapy. Musculoskeletal disorders is anticipated to dominate attributing to increasing burden of population with lower back pain. The cold pain therapy market has its distribution through hospitals pharmacies, online pharmacies, retail pharmacies. Retail pharmacies are expected to lead in the Asia Pacific cold pain therapy market as the region has growing number of retail pharmacies offering cold pain therapy products. The Asia Pacific cold pain therapy market is studied for the following countries like China, India, Japan and Rest of APAC.
Why to buy this report:
